Nywerhede
Showing 261–270 van 290 results
-
Bladder Cancer Market in China
According to StrategyHelix, the bladder cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.1% oor die ontledingstydperk van 2021 aan 2027.
-
Pancreatic Cancer Market in China
According to a statistic by StrategyHelix, the pancreatic cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.3% gedurende die voorspellingsperiode (2021-2027).
-
Lymphoma Market in China
According to StrategyHelix, the lymphoma market in China, in terms of volume, is expected to expand at a CAGR of 2.3% in the next five years.
-
Urothelial Cancer Market in China
According to a statistic by StrategyHelix, the urothelial cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.2% van 2021 through 2027.
-
Gastric Cancer Market in China
The gastric cancer market in China was estimated at 470 thousand units in 2020 and is anticipated to reach 579 thousand units by 2027, vorder teen 'n CAGR van 3% throughout the forecast period, according to StrategyHelix.
-
Breast Cancer Market in China
According to StrategyHelix, the breast cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.2% van 2021 through 2027.
-
Non-small-cell Lung Carcinoma (NSCLC) Market in China
At 3% CAGR, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 thousand units by 2027, volgens die data- en ontledingsmaatskappy StrategyHelix.
-
Nasopharyngeal Cancer Market in China
According to a statistic by StrategyHelix, the nasopharyngeal cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.2% in the next five years.
-
Head and Neck Cancer Market in China
The head and neck cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.7% van 2021 through 2027, volgens die data- en ontledingsmaatskappy StrategyHelix.
-
Oncology Drug Market in China
The oncology drug market in China is poised to grow at a CAGR of around 13.3% oor die ontledingstydperk van 2021 aan 2027, volgens die data- en ontledingsmaatskappy StrategyHelix.